skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Can you please briefly compare the 3 tagged companies in terms of how cheap they are on a valuation basis, their international exposure, and their expected growth rates?

If you had to pick 1 or 2 of them to put money in now what would you choose?

Thank you.
Read Answer Asked by Arthur on May 01, 2016
Q: I've read your last two "short term " trade thoughts on CUS, indicating that the easy money has been made.
I too thank you for this trade and have done well with it. I still hold both stocks, having put in 2/3 in CUS and the other1/3 in SPB. My question is the market seems to be still discounting the takeover for if it was to happen at today's closing price CUS could be worth $1.65. If you still like SPB why should I sell CUS? It would seem to me that they tend to follow each other.
Many Thanks for your excellent research.
Read Answer Asked by Robert on May 01, 2016
Q: Love the new format ... can you tell me if you think the negative news on Fracking (waste water) will have a positive effect on the price of oil and will these oil companies stock prices just hover with the price of oil? Thanks for all you do and especially AEM.
Read Answer Asked by Alan on April 29, 2016
Q: Since we have "bail-in" legislation in Canada and since, as people whom deposit savings in banks, we are considered "investors" in those banks and subject to "bail-ins", how would cash simply left in brokerage accounts be treated in "bail-ins"? As we receive zero interest on cash in brokerage accounts, we could not be considered "investors". Seems a safer place to hold cash than a bank account. Thanks.
Read Answer Asked by John on April 29, 2016
Q: I currently own shares in XTC and I am considering adding more. I am hoping you can give me the opposing argument. RBC shows 2017 est earnings of $1.59 which means forward p/e 8.7. There is zero debt, and earnings growth of 28% 2015-2017 (0.96-1.59). Why would I consider selling rather than buying?
As usual, many thanks for your considered response.
Mike
Read Answer Asked by michael on April 29, 2016
Q: As a followup to my CRJ.TO question (and thx), are you suggesting that Claude's stock price moving forward is limited/tied to the SSO price due to the upcoming acquisition, and to simply steer clear? I was actually unaware of SSO's interest in the company. If so, is there another smaller gold miner worth considering in its place vs FR. Thanks again for the heads up. Ron
Read Answer Asked by Ron on April 29, 2016
Q: I have invested in Sherritt bonds in the past when they came under pressure and made capital gains at maturity. I am looking at the bonds that are due November 15, 2017 with a coupon of 8% and priced at $51.50 per $100.00 plus accrued interest and was wondering what your thoughts would be of purchasing $10,000.00 face value for approximately $5,550.00 and holding till maturity.
Thank you
Read Answer Asked by Isabel on April 29, 2016
Q: I currently have no gold exposure & recent action has certainly caught my attention. What is your opinion on Claude Resources?
I am considering an initial combined purchase of AEM, CRJ, and RIC when/if there is a bit of a consolidation or pullback. What would you suggest as an allocation percentage? I've really appreciated reading your unbiased guidance over the years. Many thx, Ron.
Read Answer Asked by Ron on April 29, 2016
Q: Hi Team, which one to choose for growth and some income, in the U.S. Health Sector, AmerisourceBergen, Baxter International or Johnson & Johnson. Thanks! Sam
Read Answer Asked by sam on April 29, 2016
Q: TD Securities has recommended PPY as an action list buy, with a 12 month target price of $10.00. What would be your evaluation of this stock?

Thanks for your help,
Glen
Read Answer Asked by Glen on April 29, 2016
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!